Lipocine Inc. (LPCN)

Nasdaq: LPCN · Pharmaceutical Preparations · Salt Lake City, US · filing with the SEC since 2011

Grade5.2

◀ Past 4.5● Present 5.9▶ Future 4.9

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Mar 10, 2026	Mar 13, 2025	Mar 7, 2024	Mar 10, 2023	Mar 9, 2022	Mar 11, 2021	Mar 13, 2020	Mar 6, 2019	Mar 12, 2018	Mar 6, 2017
Revenue	1,976,677	11,198,144	-2,850,818	500,000	16,140,838	0	164,990	428,031	0	0
Research and development	8,583,919	7,351,753	10,175,251	8,556,888	7,665,559	9,748,469	7,468,210	6,464,708	11,004,281	8,076,053
General and administrative	3,764,137	5,001,426	4,904,888	4,062,487	5,329,776	8,247,795	5,597,070	5,289,142	10,213,695	10,382,146
Total operating expenses	12,348,056	12,353,179	15,080,139	12,619,375	12,995,335	17,996,264	13,065,280	11,753,850	21,217,976	19,186,834
Operating income	-10,371,379	-1,155,035	-17,930,957	-12,119,375	3,145,503	-17,996,264	-12,900,290	-11,325,819	-21,217,976	-19,186,834
Interest expense	·	·	·	27,098	203,292	386,618	766,745	·	·	·
Interest and investment income	744,074	1,146,902	1,366,940	572,578	67,700	75,650	423,491	·	·	·
Other income (expense), net	·	·	·	1,361,420	-3,779,702	-2,968,355	-106,854^r	-333,503	235,816	216,078
Total non-operating income (expense)	744,074	1,164,068	1,579,630	1,361,420	·	·	·	·	·	·
Income before income taxes	-9,627,305	9,033	-16,351,327	-10,757,955	-634,199	-20,964,619	-13,007,144	-11,659,322	-20,982,160	-18,970,756
Income tax expense	200	681	755	681	200	200	200	700	700	752
Net income	-9,627,505	8,352	-16,352,082	-10,758,636	-634,399	-20,964,819	-13,007,344	-11,660,022	-20,982,860	-18,971,508
Preferred dividends	·	·	89	·	·	·	·	·	·	·
Net income to common shareholders	·	8,352	-16,352,171	-10,758,636	-634,399	-20,964,819	-13,007,344	-11,660,022	-20,982,860	-18,971,508
Earnings per share, basic	-1.77	·	-3.10	-2.06^r	-0.1691^b	-6.4254^b	-8.4545^b	-9.30^b	-17.7545^b	-17.5854^b
Earnings per share, diluted	-1.69	·	-3.14	-2.15^r	-0.1691^b	-6.4254^b	-8.4545^b	-9.30^b	-17.7545^b	-17.5854^b
Weighted average shares, basic	5,448,871	5,338,957	5,269,671	5,231,681^r	5,141,313^b	3,293,393^b	1,530,678^b	1,262,777^b	1,185,871^b	1,079,787^b
Weighted average shares, diluted	5,708,238	5,422,604	5,269,671	5,256,169^r	5,182,051^rb	3,293,393^b	1,530,678^b	1,262,777^b	1,185,871^b	1,079,787^b

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the change of share basis.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldus-gaap:Revenues

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing costus-gaap:InterestExpense

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before tax

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Preferred dividends paid to preferred holders before common shareholdersus-gaap:PreferredStockDividendsIncomeStatementImpact

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

SI Assistanton LPCN · research, not advice